Ares Acquisition III prices $345M upsized IPO at $10.00 per unit
Ares Acquisition Corporation III priced its upsized IPO of 34.5M units at $10.00 per unit, totaling $345 million. Units list on NYSE as AAC.U starting June 30, 2026. J.P. Morgan and Jefferies acted as joint book-runners.
*this image is generated using AI for illustrative purposes only.
Ares Acquisition Corporation III has priced its upsized initial public offering of 34,500,000 units at $10.00 per unit, raising $345 million. The special purpose acquisition company formed to enter into a combination with one or more businesses will not be limited to a particular industry or geographic region for its target acquisition. The units are expected to begin trading on the New York Stock Exchange under the ticker symbol "AAC.U" on June 30, 2026.
Each unit consists of one Class A ordinary share and one-tenth of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the New York Stock Exchange under the symbols "AAC" and "AAC WS," respectively.
J.P. Morgan and Jefferies are acting as joint book-runners and underwriters for the offering. The underwriters have been granted a 45-day option to purchase up to an additional 5,175,000 units at the initial public offering price to cover over-allotments.
Key Offering Details
| Component | Details |
|---|---|
| Total Units | 34,500,000 |
| Price per Unit | $10.00 |
| Total Proceeds | $345,000,000 |
| Warrant Exercise Price | $11.50 per share |
| Over-allotment Option | 5,175,000 units |
The registration statement relating to the securities became effective on June 29, 2026, in accordance with Section 8(a) of the Securities Act of 1933. The offering is expected to close on July 1, 2026, subject to customary closing conditions.
How will the current SPAC market conditions in 2026 influence Ares Acquisition Corporation III's ability to identify and secure a suitable target?
What specific sectors or geographies is the management team prioritizing given the lack of industry restrictions?
Will the underwriters exercise the over-allotment option, and what signals would this send about investor demand?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
